Briefing
Multiparameter flow cytometry and ClonoSEQ correlation to evaluate precursor B-lymphoblastic leukemia measurable residual disease.
The study correlated Children's Oncology Group flow cytometry with clonoSEQ for measurable residual disease in precursor B-lymphoblastic leukemia.
- Design: Evidence level 3
- Assay: clonoSEQ
Journal of HematopathologyPubMed 38175444DOI 10.1007/s12308-023-00544-9